Rock Health

Digital health innovations can offer scalable, substantive impact in the youth mental health space—but solutions must be built with intention and informed by what is working and where gaps remain. Next week, RockHealth.org CEO Katie Drasser will to dig into the opportunities for youth mental health at #BHT2024, alongside our partners in the Digital Youth Mental Health Initiative Kelsey Noonan (Pivotal Ventures), Erin Sietstra (Hopelab), David Ball (SecondMuse), and John Bailey (Fiore Ventures LLC). If you’ll be there, don’t miss their conversation “Parsing the Signals through the Noise: The Investment Opportunity in Youth Mental Health Innovation” on Tuesday, November 5 at 10:30am! 

📢 Calling all primary care physicians! Rock Health and the American Academy of Family Physicians are gathering insights from primary care physicians to shape the future of AI and digital health in clinical practice. Participate in our “Use of Digital Health and AI in Primary Care” survey to directly influence solutions aimed at improving care delivery and easing operational challenges. Make your voice heard—take the survey by November 4: https://lnkd.in/gn4Qc75n  Learn more about the Advancing AI and Digital Health for Primary Care Initiative: https://lnkd.in/g5ZSE7a4 #HealthcareInnovation #DigitalHealth #AIinHealthcare #PrimaryCareInnovation

It seems not a day goes by without a new headline about GLP-1s—the weight care space is constantly evolving and many uncertainties remain. On November 13, Rock Health Advisory will host a webinar designed to answer the burning questions of enterprise innovation leaders interested in building, buying, or implementing solutions in the weight care space. Through conversations with our panelists Elina Onitskansky (Ilant Health), Kevin Kumler (Virta Health), Brooke Boyarsky Pratt (knownwell), and Cara Bohon (Equip), we will shed light on emerging trends in weight care and explore: • What happens with compounded GLP-1 options (and the companies that are offering them) as GLP-1 shortages are resolved?  • Are weight care drugs a “lifetime drug” or not? Is it realistic to expect to wean people off—and if so, what support will they need?  • What impact might weight care drugs have on mental health and health outcomes more broadly? 📅 November 13, 2024 ⏰ 9 AM PT/12 PM ET  ➡️ Register here: https://lnkd.in/gFXveru5 #WeightCare #DigitalHealth #HealthcareInnovation

It seems not a day goes by without a new headline about GLP-1s—the weight care space is constantly evolving and many uncertainties remain. On November 13, Rock Health Advisory will host a webinar designed to answer the burning questions of enterprise innovation leaders interested in building, buying, or implementing solutions in the weight care space. Through conversations with our panelists Elina Onitskansky (Ilant Health), Kevin Kumler (Virta Health), Brooke Boyarsky Pratt (knownwell), and Cara Bohon (Equip), we will shed light on emerging trends in weight care and explore: • What happens with compounded GLP-1 options (and the companies that are offering them) as GLP-1 shortages are resolved?  • Are weight care drugs a “lifetime drug” or not? Is it realistic to expect to wean people off—and if so, what support will they need?  • What impact might weight care drugs have on mental health and health outcomes more broadly? 📅 November 13, 2024 ⏰ 9 AM PT/12 PM ET  ➡️ Register here: https://lnkd.in/gFXveru5 #WeightCare #DigitalHealth #HealthcareInnovation

When your panelists are this good, moderating is easy! I really enjoyed moderating a discussion yesterday at HLTH Inc. on the topic - Are GLP-1s a Miracle Cure or Healthcare’s Breaking Point? The TLDR: probably a little bit of both.  Thanks so much to Terry Gilliland, Florencia Halperin, Elliott Green, and Kavita Patel for sharing your perspectives on this critical topic! Below are a few insights from the conversation: 💵 At today's prices, GLP-1s are not affordable for our health system and we are "upside down" on ROI in a several year horizon. (At Geisinger, GLP-1s were 10% of the medical cost this year and that was just for a small percent of the population) ❓ There's a lot we know about GLP-1s (e.g. clinical trial data), but there's also a lot we don't know like who they work best for, what are the effects on pregnancy (incredibly important bc of the "ozempic babies" phenomenon and the fertility boost that comes with losing weight) and what the long term impacts will be on lean muscle mass and overall health. Dandelion Health will be digging into the data, but it will take years to know. With a huge number of GLP-1 medications in clinical trials, getting this information will be critical. 🪆 Comprehensive care to support nutrition, muscle building, and medication management (like those offered by Form Health) are a critical component of care, but many individuals are being prescribed by primary care physicians who don't have the capacity, training and resources to deliver those programs. 💉 Access and costs are driving many consumers to use compounded medications that are of unknown quality and hard to administer correctly, often from companies that are not providing oversight and care. 🧬 We need data driven pathways and phenotyping to help us build better models on what the right treatment journey is for each individual, and we also need more flexibility to prescribe the right dose and duration for each patient (today starter prescriptions are minimum six months supply despite 30% of consumers stopping after 3 months, and doses are set at fixed levels.) 🍎 Are the costs and considerations of GLP-1s distracting us from solving systemic root cause issues such as national healthy food supply and education to address our national obesity pandemic? #HLTHUSA #digitalhealth #weightcare #GLP-1s Rock Health

Another #HLTHUSA has come and gone—as always, the Las Vegas of it all offered a plethora of panels, meetings, happy hours, announcements aplenty, and many compelling moments to reflect on. Our Rock Health crew may be biased, but one of our favorites took place in the early AM hours, when we brought together a group of Rock Health Advisory clients and friends for breakfast and candid conversation. With the help of our amazing panelists Megann Watters (Labcorp), Zachary Clark (Uber Health), Ethan Fischer (K Health), and Lauren Lisher (Mount Sinai Health System), we explored: • What we’ve dubbed as the age of “consumer-native” care delivery and how healthcare expectations are evolving as a result • New care paradigms reshaping payer, provider, and pharma strategies • How retailers and big tech are leveraging consumer-centricity • How digital health innovators can “weave tapestries” to build comprehensive solutions The insights and energy from this gathering set the tone for a week filled with meaningful discussions about transforming healthcare delivery. Until next year! + Are you an enterprise innovation leader who wants to attend future Rock Health Advisory events? Email [email protected] to learn more!  #consumernativecare #digitalhealth #healthcareinnovation

Conference season is in full swing—who else is heading to #BioFuture2024 next week? Join us on Tuesday, 10/29 as Rock Health Advisory’s Chief Commercial Officer, Sari Kaganoff, moderates “The Next Frontier of Obesity Care.” The session will delve into this rapidly evolving landscape, focusing on the rise of GLP-1s and their potential impact on healthcare delivery and economics. Expect to learn about anticipated changes to care paradigms, potential health and financial implications of widespread GLP-1 use, and how to navigate market disruptions to healthcare system impact and beyond. Joining Sari is an incredible group of experts from across the ecosystem:  • Dianna Budgeon, SVP, Clinical Operations, knownwell • Dan Knecht, MD MBA, Chief Clinical Innovation Officer, CVS Caremark • Sloan Saunders, CEO & Co-Founder, FlyteHealth • Adam Wolfberg, Chief Medical Officer, Virta Health • Rich Yang, CEO, Biolinq If you're attending #BioFuture2024, we’d love to see you there! + for more on this topic, check out Rock Health Advisory’s insights on consumer perspectives of weight care: https://lnkd.in/ej23yeKA

Continuing our series on the 2024 RockHealth.org Innovation Fellows, today we're highlighting Nicole Cook, Founder + CEO of alvee. Alvee is an AI-driven health equity platform that helps providers integrate social determinants of health into clinical workflows. The solution brings distinct value by integrating AI-driven insights and autonomous care navigation directly into healthcare workflows. Alvee's focus on health equity rehumanizes healthcare delivery, making them a pioneer in leveraging technology to address systemic disparities. https://lnkd.in/gRCKpeQG

The RockHealth.org Innovation Fellowship is an immersive cohort-based experience that supports and amplifies the work of visionary leaders who are centering lived experience in digital health innovation. The 2024 Fellows are a dynamic group of leaders pioneering advancements in food and nutrition, personalized medicine, mental and behavioral health, and more. The Innovation Fellows represent a diverse range of perspectives and expertise, and we're excited to highlight each Fellow and their work over the next few months. https://lnkd.in/dyzmrbBm We're kicking off with Emily Brown, Co-Founder + CEO of Attane Health. Emily and her team are focused on providing underserved patients, primarily Medicaid recipients, with the high-quality food, nutrition support and health coaching they need to help manage their chronic health conditions, improve health outcomes, and lower the cost of care. Emily is a former Medicaid beneficiary from Kansas who is humbled to be building a solution that ensures other families do not have to experience the challenges that she did. https://lnkd.in/g6P_jJVg

🧵Pulling the thread on the digital health “tapestries" trend While overall M&A activity in digital health has slowed in 2024 (21 deals in Q3, down from 28 in Q2, 37 in Q1), an interesting trend we’ve dubbed "tapestry weaving" has emerged. Rather than acquiring like competitors, digital health companies are using M&A to integrate new features and capabilities into their offerings. Like weaving a tapestry, these deals stitch together different solutions to create more robust solutions that address a broader range of customer needs. Why this matters: • After periods of startup valuation recalibration, acquiring built-out products can be more cost-effective than building from scratch • Companies can rapidly expand their capabilities and market reach • This approach creates more robust solutions poised to serve healthcare's biggest players While this approach doesn’t come easily—or always succeed—we expect this trend to continue as companies seek to compete for healthcare's most lucrative opportunities. Success will depend on how well these tapestries are woven, from product integration to unified go-to-market strategies. + For more on this trend, read our Q3 recap by Adriana Krasniansky, Sari Kaganoff, and Tiffany Ramos: https://lnkd.in/gMt3JuQC + Want industry-leading market intelligence, custom insights, or support identifying and evaluating opportunities in this rapidly evolving market? Rock Health Advisory is here to help. Reach us at [email protected]